372 related articles for article (PubMed ID: 8130906)
1. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with human papillomavirus infection in women encountered in community-based offices.
Reed BD; Zazove P; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT
Arch Fam Med; 1993 Dec; 2(12):1239-48. PubMed ID: 8130905
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
Nuovo GJ; Blanco JS; Leipzig S; Smith D
Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
6. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
7. Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.
Zazove P; Reed BD; Gregoire L; Ferenczy A; Gorenflo DW; Lancaster WD
J Clin Microbiol; 1998 Sep; 36(9):2708-13. PubMed ID: 9705418
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
9. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC
Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518
[TBL] [Abstract][Full Text] [Related]
10. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous evolution of human papillomavirus infection in the uterine cervix.
Paraskevaidis E; Kalantaridou SN; Georgiou I; Koliopoulos G; Pappa L; Malamou-Mitsi V; Agnantis NJ; Kitchener HC; Lolis DE
Anticancer Res; 1999; 19(4C):3473-8. PubMed ID: 10629638
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
[TBL] [Abstract][Full Text] [Related]
14. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
[TBL] [Abstract][Full Text] [Related]
15. HPV testing in primary screening of older women.
Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear.
De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
J Virol Methods; 2008 Jan; 147(1):10-7. PubMed ID: 17854914
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear.
Burk RD; Kadish AS; Calderin S; Romney SL
Am J Obstet Gynecol; 1986 May; 154(5):982-9. PubMed ID: 3010725
[TBL] [Abstract][Full Text] [Related]
19. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
